129 related articles for article (PubMed ID: 12760682)
1. Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H; M-1 and M-2.
Muramatsu Y; Miyakoshi S; Ogawa Y; Ohnuki T; Ishii MM; Arai M; Takatsu T; Inukai M
J Antibiot (Tokyo); 2003 Mar; 56(3):259-67. PubMed ID: 12760682
[TBL] [Abstract][Full Text] [Related]
2. Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.
Muramatsu Y; Muramatsu A; Ohnuki T; Ishii MM; Kizuka M; Enokita R; Tsutsumi S; Arai M; Ogawa Y; Suzuki T; Takatsu T; Inukai M
J Antibiot (Tokyo); 2003 Mar; 56(3):243-52. PubMed ID: 12760680
[TBL] [Abstract][Full Text] [Related]
3. A-503083 A, B, E and F, novel inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 62799.
Muramatsu Y; Ohnuki T; Ishii MM; Kizuka M; Enokita R; Miyakoshi S; Takatsu T; Inukai M
J Antibiot (Tokyo); 2004 Oct; 57(10):639-46. PubMed ID: 15638324
[TBL] [Abstract][Full Text] [Related]
4. Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.
Ohnuki T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
J Antibiot (Tokyo); 2003 Mar; 56(3):268-79. PubMed ID: 12760683
[TBL] [Abstract][Full Text] [Related]
5. Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.
Muramatsu Y; Ishii MM; Inukai M
J Antibiot (Tokyo); 2003 Mar; 56(3):253-8. PubMed ID: 12760681
[TBL] [Abstract][Full Text] [Related]
6. A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. SANK 60206.
Murakami R; Fujita Y; Kizuka M; Kagawa T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
J Antibiot (Tokyo); 2007 Nov; 60(11):690-5. PubMed ID: 18057698
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.
Hotoda H; Furukawa M; Daigo M; Murayama K; Kaneko M; Muramatsu Y; Ishii MM; Miyakoshi S; Takatsu T; Inukai M; Kakuta M; Abe T; Harasaki T; Fukuoka T; Utsui Y; Ohya S
Bioorg Med Chem Lett; 2003 Sep; 13(17):2829-32. PubMed ID: 14611838
[TBL] [Abstract][Full Text] [Related]
8. Studies on novel bacterial translocase I inhibitors, A-500359s. V. Enhanced production of capuramycin and A-500359 A in Streptomyces griseus SANK 60196.
Muramatsu Y; Arai M; Sakaida Y; Takamatsu Y; Miyakoshi S; Inukai M
J Antibiot (Tokyo); 2006 Sep; 59(9):601-6. PubMed ID: 17136893
[TBL] [Abstract][Full Text] [Related]
9. Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics.
Kimura KI
J Antibiot (Tokyo); 2019 Dec; 72(12):877-889. PubMed ID: 31582803
[TBL] [Abstract][Full Text] [Related]
10. A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity.
Murakami R; Fujita Y; Kizuka M; Kagawa T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
J Antibiot (Tokyo); 2008 Sep; 61(9):537-44. PubMed ID: 19160520
[TBL] [Abstract][Full Text] [Related]
11. A-90289 A and B, new inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 60405.
Fujita Y; Kizuka M; Funabashi M; Ogawa Y; Ishikawa T; Nonaka K; Takatsu T
J Antibiot (Tokyo); 2011 Jul; 64(7):495-501. PubMed ID: 21587261
[TBL] [Abstract][Full Text] [Related]
12. A-94964, novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. II. Physico-chemical properties and structure elucidation.
Fujita Y; Murakami R; Muramatsu Y; Miyakoshi S; Takatsu T
J Antibiot (Tokyo); 2008 Sep; 61(9):545-9. PubMed ID: 19160521
[TBL] [Abstract][Full Text] [Related]
13. The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.
Cai W; Goswami A; Yang Z; Liu X; Green KD; Barnard-Britson S; Baba S; Funabashi M; Nonaka K; Sunkara M; Morris AJ; Spork AP; Ducho C; Garneau-Tsodikova S; Thorson JS; Van Lanen SG
J Biol Chem; 2015 May; 290(22):13710-24. PubMed ID: 25855790
[TBL] [Abstract][Full Text] [Related]
14. Identification of the biosynthetic gene cluster of A-500359s in Streptomyces griseus SANK60196.
Funabashi M; Nonaka K; Yada C; Hosobuchi M; Masuda N; Shibata T; Van Lanen SG
J Antibiot (Tokyo); 2009 Jun; 62(6):325-32. PubMed ID: 19478828
[TBL] [Abstract][Full Text] [Related]
15. Two novel nucleosidyl-peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS.
Xie Y; Xu H; Sun C; Yu Y; Chen R
J Antibiot (Tokyo); 2010 Mar; 63(3):143-6. PubMed ID: 20139866
[No Abstract] [Full Text] [Related]
16. Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors.
Siricilla S; Mitachi K; Wan B; Franzblau SG; Kurosu M
J Antibiot (Tokyo); 2015 Apr; 68(4):271-8. PubMed ID: 25269459
[TBL] [Abstract][Full Text] [Related]
17. Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins.
Igarashi M; Takahashi Y; Shitara T; Nakamura H; Naganawa H; Miyake T; Akamatsu Y
J Antibiot (Tokyo); 2005 May; 58(5):327-37. PubMed ID: 16060385
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
Dini C; Collette P; Drochon N; Guillot JC; Lemoine G; Mauvais P; Aszodi J
Bioorg Med Chem Lett; 2000 Aug; 10(16):1839-43. PubMed ID: 10969981
[TBL] [Abstract][Full Text] [Related]
19. Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity.
Takahashi Y; Igarashi M; Miyake T; Soutome H; Ishikawa K; Komatsuki Y; Koyama Y; Nakagawa N; Hattori S; Inoue K; Doi N; Akamatsu Y
J Antibiot (Tokyo); 2013 Mar; 66(3):171-8. PubMed ID: 23532021
[TBL] [Abstract][Full Text] [Related]
20. Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.
Patel B; Ryan P; Makwana V; Zunk M; Rudrawar S; Grant G
Eur J Med Chem; 2019 Jun; 171():462-474. PubMed ID: 30933853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
